Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D001923:Brain Chemistry; D002421:Caudate Nucleus / Q000201:enzymology; D002490:Central Nervous System / Q000187:drug effects; D004298:Dopamine / Q000008:administration & dosage / Q000032:analysis / Q000378:metabolism* / Q000494:pharmacology*; D007275:Injections, Intravenous; D008297:Male; D006899:Mixed Function Oxygenases / Q000378:metabolism; D009474:Neurons / Q000187:drug effects; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism*; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000032:analysis; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism
D014316:Tritium; D012701:Serotonin; D014443:Tyrosine; D010293:Pargyline; D006899:Mixed Function Oxygenases; D004298:Dopamine; D009638:Norepinephrine